cyclosporine has been researched along with Liver Dysfunction in 112 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 42 (37.50) | 18.2507 |
| 2000's | 51 (45.54) | 29.6817 |
| 2010's | 17 (15.18) | 24.3611 |
| 2020's | 2 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Dimopoulos, C; Kontzoglou, K; Nikiteas, N; Papadakis, M; Perrea, D | 1 |
| Cai, Q; Chen, C; Chen, J; Huang, X; Jiang, Y; Ke, R; Liu, J; Xu, F; Yang, F | 1 |
| Aguiar, D; Baroja-Mazo, A; Casafont, F; Cuadrado, A; de la Mata, M; Herrero, JI; Martínez-Urbistondo, D; Montero, J; Pons, JA; Puchades, L; Rincón, D; Rodríguez-Perálvarez, M; Rubín, A; Salcedo, M; Serrano, T | 1 |
| Berti, E; Damiani, G; Fiore, M; Leone, S; Maraolo, AE | 1 |
| Abo-Hamra, E; Abu-El-Naga, H; Al-Khalidi, JA; Al-Qabandy, W; Alenezi, B; Askar, HA; Husain, K; Jagannathan, AP; Neff, GW | 1 |
| Fukushima, K; Ichikawa, H; Koyama, H; Miki, T; Nakamoto, K; Nishimura, A; Shibata, N; Sugioka, N; Tokuyama, S | 1 |
| Aspeslet, LJ; Foster, RT; Freitag, DG; Huizinga, RB; Ling, SY; Mayo, PR | 1 |
| Fischer, L; Gotthardt, D; Heyne, N; Kaiser, GM; Klein, CG; Ladenburger, S; Lehner, F; Loss, M; Mertens, M; Nadalin, S; Neuhaus, P; Pascher, A; Paulus, EM; Rauchfuss, F; Richter, N; Schemmer, P; Schlitt, HJ; Settmacher, U; Sterneck, M | 1 |
| Choi, YH; Jung, SH; Kim, HS; Kim, SG; Ko, MS; Lee, CH; Lee, JS | 1 |
| Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J | 1 |
| Arai, Y; Atsuta, Y; Eto, T; Fukuda, T; Hirokawa, M; Iwato, K; Kaida, K; Kanda, J; Kanda, Y; Kondo, T; Morishima, Y; Murata, M; Nagamura-Inoue, T; Nakamae, H; Nakasone, H; Ohashi, K; Uchida, N | 1 |
| Bican Demir, A; Bora, I; Erer Özbek, S; Hakyemez, B; Kaya, E; Tırnova, I | 1 |
| Lenert, A; Yao, Q | 1 |
| Hai, C; Li, S; Liao, N; Liu, J; Liu, R; Wang, X; Yu, W; Zhang, T; Zhang, X | 1 |
| Pari, L; Sivasankari, R | 1 |
| Boillot, O; Cochat, P; Dubourg, L; Hadj-Haïssa, A; Harambat, J; Lachaux, A; Liutkus, A; Ranchin, B; Rivet, C | 1 |
| Cederbaum, AI; Zhuge, J | 1 |
| Allen, CE; Horton, T; Jones, JY; McClain, KL; Thompson, PA; Vinks, AA | 1 |
| Benito, MJ; Casafont, F; Fábrega, E; López-Hoyos, M; Pons-Romero, F; San Segundo, D | 1 |
| Anasetti, C; Appelbaum, FR; Carnevale-Schianca, F; Carpenter, PA; Deeg, HJ; Furlong, T; Kiem, HP; Leisenring, W; Martin, PJ; McDonald, GB; Nash, RA; Schoch, G; Storb, R | 1 |
| Fox, LP; Goddard, DS; Mathes, ED; Nixon, M; Ruben, BS; Wolf, J | 1 |
| Beckebaum, S; Cicinnati, VR; Gerken, G; Klein, C; Paul, A; Saner, F; Schmitz, K; Sotiropoulos, GC; Varghese, J | 1 |
| Abradelo, M; Colina, F; Fernández, I; Gimeno, A; Jiménez, C; Lumbreras, C; Meneu, JC; Moreno, E; Solís-Herruzo, JA; Ulloa, E | 1 |
| Beckebaum, S; Broelsch, CE; Cicinnati, V; Dammann, M; Gensicke, J; Kaiser, GM; Koeppen, S; Malagó, M; Nadalin, S; Olde Damink, SW; Paul, A; Pavlaković, G; Radtke, A; Saner, FH; Sotiropoulos, GC; Treckmann, J | 1 |
| Albano, L; Aoudia, R; Berthoux, F; Cassuto, E; Dahan, P; Gugenheim, J; Niel, OR | 1 |
| Castroagudín, JF; Molina, E; Otero, E; Romero, R; Tomé, S; Varo, E | 1 |
| Bondada, S; Brandon, JA; Bryson, JS; Cohen, DA; Jennings, CD; Kaplan, AM; Perez, J; Sindhava, VJ | 1 |
| Baier, L; Bein, T; Doenecke, A; Farkas, SA; Geissler, EK; Hartl, J; Kirchner, G; Loss, M; Obed, A; Scherer, MN; Schlitt, HJ; Schnitzbauer, AA; Sothmann, JL; Tsui, TY | 1 |
| Chan, AJ; Lake, JR | 1 |
| Bearman, SI; Ecder, T; Jones, RB; Korular, D; McSweeney, PA; Merouani, A; Parikh, CR; Schrier, RW; Shpall, EJ; Slat-Vasquez, V; Taylor, J | 1 |
| Kobayashi, T; Maeshima, E; Mune, M; Yukawa, S | 1 |
| Cheeseman, P; Dhawan, A; Heaton, N; Mieli-Vergani, G; Rela, M; Taylor, RM | 1 |
| Berquist, R; Berquist, W; Cox, K; Esquivel, C; Millan, M; Zajicek, A | 1 |
| Arning, A; Ehrich, JH; Melter, M; Nashan, B; Pfister, ED; Strassburg, A | 1 |
| Chen, XC; Xu, Q | 1 |
| Biancofiore, G; Bindi, L; Bisà, M; Boldrini, A; Consani, G; Danella, A; Filipponi, F; Mosca, F; Romanelli, AM; Urbani, L | 1 |
| Benet, LZ; Hebert, MF; Roberts, JP; Wacher, VJ | 1 |
| Moreno, AJ; Oliveira, PJ; Palmeira, CM; Rolo, AP; Santos, MS; Seiça, R | 1 |
| Bjøro, K; Bjøro, T; Bollerslev, J; Brandsaeter, B; Godang, K; Schrumpf, E; Wiencke, K | 1 |
| Benkoël, L; Chanussot, F | 1 |
| Baraldo, M; Bresadola, F; Chiarandini, P; Dalla Rocca, G; Furlanut, M; Risaliti, A | 1 |
| Amaral, DD; Copstein, JL; D'Albuquerque, LA; Garcia, CE; Garcia, RL; Padilla, JM; Ribeiro, HB; Santos, TE; Silva, AO | 1 |
| Caprai, S; Maggiore, G; Palla, G; Sciveres, M; Ughi, C | 1 |
| Boillot, O; Grazi, GL; Klintmalm, G; Levy, G; Marotta, P; Muehlbacher, F; Samuel, D; Sanjuan, F; Villamil, F; Wu, Y | 1 |
| Broering, DC; Burdelski, M; Ganschow, R; Grabhorn, E; Helmke, K; Hinrichs, B; Rogiers, X; Schulz, A | 1 |
| Ke, QH; Liang, TB; Shen, Y; Wang, WL; Yu, J; Zheng, SS | 1 |
| Morin, D; Pires, F; Plin, C; Tillement, JP | 1 |
| Klintmalm, GB; Testa, G | 1 |
| Tadano, K; Yuhki, Y | 1 |
| Abdelmalek, MF; Gagliardi, R; Granger, D; Holt, C; Kam, I; Klintmalm, G; Langnas, A; Lucey, MR; Shetty, K; Tzakis, A; Woodle, ES | 1 |
| Evans, HM; Kelly, DA; McKiernan, PJ | 1 |
| Bianchi, R; Buffoli, B; Rezzani, R; Rodella, L; Stacchiotti, A | 1 |
| Riely, CA; Shokouh-Amiri, MH; Tombazzi, CR; Vera, SR; Waters, B | 1 |
| Bolderson, I; Clark, B; Cook, G; Gooi, HC; Kinsey, S; Stephens, E | 1 |
| Fujiwara, M; Hori, A; Kami, M; Kanda, Y; Komatsu, T; Koyama, R; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Seki, K; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K | 1 |
| Fujii, M; Ikemoto, T; Imura, S; Morine, Y; Ogasawara, T; Shimada, M; Shinohara, H | 1 |
| Durgut, R; Duru, M; Kaya, H; Koc, A; Sogut, S; Uz, E; Yilmaz, HR | 1 |
| Hatano, E | 1 |
| Adams, PC; Assy, N; Ghent, CN; Minuk, GY; Myers, P; Simon, V; Wall, W | 1 |
| Berlakovich, GA; Burghuber, C; Györi, G; Hetz, H; Mühlbacher, F; Silberhumer, G; Soliman, T; Steininger, R | 1 |
| Alvarez-López, MR; Carballo, F; Egea, J; Martínez, C; Miras, M; Parrilla, P; Sánchez-Bueno, F | 1 |
| Benet, LZ; Browne, M; Carlson, L; Cheng, A; Frassetto, LA; Roland, ME; Stock, PG; Wolfe, AR | 1 |
| Chapman, W; Crippin, J; Hardinger, KL; Korenblat, K; Lisker-Melman, M; Lowell, JA; Shenoy, S | 1 |
| Jensen, GS; Trotter, JF; Wiseman, A | 1 |
| DuBay, D; Levy, GA; Lilly, L; Qiu, KG; Smith, RJ; Therapondos, G | 1 |
| Bismuth, H | 1 |
| Burnett, JC; Canzanello, VJ; Gores, G; Hay, E; Krom, R; Porayko, M; Romero, JC; Taler, SJ; Textor, SC; Wiesner, R | 1 |
| Färber, L; Kattner, A; Maibücher, A; Oldhafer, K; Pichlmayr, R; Ringe, B; Winkler, M; Wonigeit, K | 1 |
| Bromberg, JS; Campbell, DA; Merion, RM; Punch, JD; Shieck, VL; Turcotte, JG | 1 |
| Gavaler, JS; Miyata, T; Starzl, TE; Todo, S; Van Thiel, DH; Yokoyama, I | 1 |
| Anderle, SK; Geratz, JD; Pryzwansky, KB; Tidwell, RR | 1 |
| Greenberg, E; Moore, RA; Tangen, L | 1 |
| Caraceni, P; Cooper, DK; Deal, S; Fagiuoli, S; Gavaler, J; Jazzar, A; Sisson, S; Van Thiel, DH; Wright, HI; Zuhdi, N | 1 |
| Aesha, H; Alfurayh, O; Almeshari, K; Alshaibani, K; Minhas, M; Qunibi, W; Sobh, M; Taher, S | 1 |
| Bismuth, H; Farges, O; Samuel, D | 1 |
| Alciati, E; Casciani, CU; Pieragostini, E; Pisani, F; Tisone, G; Vennarecci, G | 1 |
| Aul, C; Borchard, F; Hadding, U; Heyll, A; Leschke, M; Meckenstock, G; Mödder, U; Schneider, W; Söhngen, D | 1 |
| Czerniak, A; Horber, F; Reichen, J; Renner, EL; Rieder, H; Seiler, CA | 1 |
| Belli, L; Belli, LS; D'Alessandro, R; Donato, MF; Erminio, F; Guarino, M; Pazzaglia, F; Santilli, I; Sterzi, R; Stracciari, A | 1 |
| Eramishantsev, AK; Goté, SV; Konstantinov, BA; Lebezev, VM; Lokshin, LS; Shertsinger, AG; Skipenko, OG; Tsirulńikova, OM | 1 |
| Brunner, G; Bunzendahl, H; Gubernatis, G; Kohlhaw, K; Muraca, M; Pichlmayr, R; Ringe, B; Vilei, MT; Wonigeit, K | 1 |
| Bixquert, V; Bueno, F; Miras, M; Parrilla, P; Pons, JA; Ramirez, P; Robles, R; Rodriguez, J | 1 |
| Bechstein, WO; Blumhardt, G; Lange, D; Lohmann, R; Neuhaus, P; Schattenfroh, N | 1 |
| Chen, RR; Chern, HD; Gau, YS; Hu, RH; Lee, PH; Tsai, KS | 1 |
| Bostrom, BC; Dehner, LP; Freyer, DR; Kennedy, R; Kohut, G | 1 |
| Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Maiello, A; Polchi, P | 1 |
| Benkerrou, M; de Graeff-Meeder, BR; Fischer, A; Haddad, E; Patey, N; Spliet, WG; Wulffraat, NM | 1 |
| Cadranel, JF; Di Martino, V; Erlinger, S | 1 |
| Brooks, RH; Pincus, T; Stein, CM | 1 |
| Ashida, R; Kohno, S; Maeda, T; Minamino, Y; Oh-I, H; Omagari, K; Ozono, Y; Sadamori, N; Sasaki, O; Tomonaga, M | 1 |
| Ascher, NL; Freise, CE; Galbraith, CA; Lake, JR; Nikolai, BJ; Roberts, JP; Stock, PG | 1 |
| Bechstein, WO; Frei, U; Kahl, A; Lang, M; Neuhaus, P; Neumann, U; Settmacher, U | 1 |
| Arumugam, R; Barakat, O; Gopalakrishna, GS; Ozaki, CF; Reid, BS; Scheimann, AO; Soriano, HE; Wood, RP | 1 |
| Detry, O; Honoré, P; Jacquet, N; Meurisse, M | 1 |
| Mazariegos, GV; Reyes, J | 1 |
| Chicharro, Mf; Guarner, L; Malagelada, J; Planas, M; Vilaseca, J | 1 |
| Chan, J; Chan, KL; Chau, MT; Fan, ST; Lo, CM; Ng, IO; Saing, H; Tam, PK; Tsoi, NS; Tsoi, WK; Wei, WI; Wong, J; Yuen, KY | 1 |
| Alejos, JC; Chang, RK; Drant, SE; Klitzner, TS; McDiarmid, SV | 1 |
| Enomoto, N; Ikejima, K; Kolinsky, M; Li, X; Raleigh, JA; Thurman, RG; von Frankenberg, M; Yamashina, S; Zhong, Z | 1 |
| Goldstein, RM; Gonwa, TA; Hays, SR; Klintmalm, GB; Levy, MF; Mai, ML; Melton, LB | 1 |
| Jiang, XL; Li, WB; Quan, QZ; Sun, ZQ; Wang, D; Wang, YJ; Zhang, XL | 1 |
| Abraham, AM; Jacob, CK; John, GT; Mathews, MS; Shankar, V; Thomas, PP | 1 |
| Abu-Elmagd, K; Alessiani, M; Demetris, AJ; Fung, JJ; Jain, A; McCauley, J; Starzl, TE; Takaya, S; Todo, S; Van Thiel, DH | 1 |
| Bhandari, M; Elhence, R; Kher, V; Naik, SR; Sharma, RK | 1 |
| Kamihira, O; Kuriki, O; Matsuura, O; Ohshima, S; Ono, Y; Sahashi, M; Takeuchi, N; Tanaka, K; Yamada, S | 1 |
| Aroldi, A; Cesana, B; Montagnino, G; Paparella, M; Ponticelli, C; Rumi, MG; Tarantino, A | 1 |
| Kolars, J; Lown, K; Merion, R; Turgeon, K; Watkins, PB; Wrighton, SA | 1 |
| Kasukawa, R; Kondo, Y; Matsuzaki, H; Nishimaki, T; Sato, Y | 1 |
| Burtomboy, G; Cames, B; de Ville de Goyet, J; Lamy, M; Otte, JB; Rahier, J; Reding, R; Sokal, EM | 1 |
| Adorno, D; Casciani, CU; Cervelli, V; Cesarini, A; Filingeri, V; Iacona, A; Orsini, D; Rossetti, A | 1 |
| Azar, N; Cabrol, A; Cadranel, JF; Desruennes, M; Grippon, P; Leger, P; Lunel, F; Moussalli, J; Pauwels, A; Salmon, P | 1 |
10 review(s) available for cyclosporine and Liver Dysfunction
| Article | Year |
|---|---|
Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis.
Topics: Adult; Calcineurin Inhibitors; Cholangiocarcinoma; Cholangitis, Sclerosing; Colectomy; Cyclosporine; End Stage Liver Disease; Enzyme Inhibitors; Female; Graft Rejection; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus | 2020 |
Liver Illness and Psoriatic Patients.
Topics: Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Inflammation; Liver; Liver Diseases; Methotrexate; Psoriasis | 2018 |
Immunosuppression in HCV-positive liver-transplant recipients.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Daclizumab; Everolimus; Hepatitis C; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2012 |
Prevention by dietary (n-6) polyunsaturated phosphatidylcholines of intrahepatic cholestasis induced by cyclosporine A in animals.
Topics: Actins; Adenosine Triphosphatases; Adenosine Triphosphate; Animal Feed; Animals; Biological Transport; Calcium; Cell Membrane; Cholestasis; Cyclosporine; Hypolipidemic Agents; Lipid Metabolism; Liver; Liver Diseases; Magnesium; Male; Models, Biological; Phosphatidylcholines; Phospholipids; Rats; Rats, Wistar | 2003 |
Cyclosporine and tacrolimus: the mainstay of immunosuppressive therapy for solid organ transplantation.
Topics: Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Survival Rate; Tacrolimus | 1997 |
[Cyclosporine].
Topics: Aging; Biomarkers; Chromatography, High Pressure Liquid; Cyclosporine; Dosage Forms; Drug Interactions; Drug Monitoring; Food-Drug Interactions; Humans; Immunoassay; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Specimen Handling | 2004 |
Tumor necrosis factor signaling in hepatocyte apoptosis.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Membrane Permeability; Chromones; Cyclosporine; Hepatocytes; Liver Diseases; Mice; Mitochondria, Liver; Morpholines; NF-kappa B; Rats; Receptors, Death Domain; Signal Transduction; Trifluoperazine; Tumor Necrosis Factors | 2007 |
Juvenile xanthogranuloma: forms of systemic disease and their clinical implications.
Topics: Anti-Inflammatory Agents; Brain Diseases; Child; Child, Preschool; Cyclosporine; Etoposide; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Lung Diseases; Male; Prednisone; Remission, Spontaneous; Skin; Splenic Diseases; Survival Rate; Treatment Outcome; Vinblastine; Xanthogranuloma, Juvenile | 1996 |
[Cyclosporin in the treatment of chronic diseases of the liver (excluding transplantation)].
Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Liver Diseases | 1997 |
Pediatric transplantation.
Topics: Child; Cyclosporine; Humans; Immunosuppressive Agents; Intestines; Kidney Transplantation; Liver Diseases; Liver Transplantation; Tacrolimus; Transplantation Chimera; Treatment Outcome; Vena Cava, Inferior | 1999 |
22 trial(s) available for cyclosporine and Liver Dysfunction
| Article | Year |
|---|---|
Pharmacokinetics of voclosporin in renal impairment and hepatic impairment.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Humans; Liver Diseases; Male; Middle Aged; Renal Insufficiency | 2013 |
Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Everolimus; Feasibility Studies; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prognosis; Prospective Studies; Sirolimus; Time Factors; Withholding Treatment; Young Adult | 2014 |
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Allografts; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Registries; Risk Factors; Survival Rate | 2016 |
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Topics: Adult; Aged; Biomarkers; Calcineurin Inhibitors; Chronic Disease; Creatinine; Cyclosporine; Drug Administration Schedule; Everolimus; Feasibility Studies; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prospective Studies; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2009 |
Pharmacokinetics of cyclosporine pre- and post-liver transplantation.
Topics: Adult; Alcoholism; Cholangitis, Sclerosing; Cyclosporine; Female; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Infusions, Intravenous; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Period | 2003 |
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.
Topics: Adult; Aged; Biopsy; Cyclosporine; Diabetes Mellitus; Emulsions; Graft Rejection; Hepacivirus; Humans; Immunosuppressive Agents; Incidence; Liver; Liver Diseases; Liver Transplantation; Middle Aged; Monitoring, Physiologic; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
Topics: Adult; Aged; Cholagogues and Choleretics; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Patient Compliance; Placebos; Prednisone; Safety; Ursodeoxycholic Acid | 2007 |
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.
Topics: Adult; Anti-Retroviral Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Pilot Projects; Sirolimus; Tacrolimus | 2007 |
A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Cost-Benefit Analysis; Cyclosporine; Drug Costs; Drug Monitoring; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tacrolimus; Time Factors | 2008 |
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.
Topics: Adult; Child; Confidence Intervals; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Liver Diseases; Liver Transplantation; Male; Tacrolimus | 1994 |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Li
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Incidence; Liver Diseases; Liver Neoplasms; Liver Transplantation; Male; Steroids; Survival Rate; Tacrolimus | 1995 |
Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients.
Topics: Absorption; Administration, Oral; Adult; Bile; Cyclosporine; Emulsions; Female; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged | 1995 |
Corticosteroid withdrawal after liver transplantation.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Humans; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Liver Diseases; Liver Function Tests; Liver Transplantation | 1995 |
Incidence and etiology of hepatic dysfunction in heart transplant recipients receiving a cyclosporine-based triple immunosuppressive therapy.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppression Therapy; Liver Diseases; Liver Function Tests; Time Factors | 1994 |
Effect of liver disease in kidney transplant recipients on cyclosporine dose and metabolite levels.
Topics: Alanine Transaminase; Analysis of Variance; Cyclosporine; Female; Follow-Up Studies; Humans; Kidney Transplantation; Liver Diseases; Liver Function Tests; Male; Time Factors | 1994 |
Cyclosporine A monitoring in liver transplant.
Topics: Antibodies, Monoclonal; Azathioprine; Biopsy, Needle; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Humans; Incidence; Liver Diseases; Liver Transplantation; Postoperative Complications; Postoperative Period | 1994 |
Neurologic complications following orthotopic liver transplantation.
Topics: Adolescent; Adult; Central Nervous System Diseases; Cerebrovascular Disorders; Child; Cyclosporine; Epilepsy; Female; Graft Rejection; Humans; Immunosuppression Therapy; Liver Diseases; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Peripheral Nervous System Diseases; Postoperative Complications | 1994 |
Cyclosporine vs OKT3 prophylaxis after orthotopic liver transplantation.
Topics: Adult; Azathioprine; Bilirubin; Creatinine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Liver Diseases; Liver Transplantation; Muromonab-CD3; Prednisolone | 1993 |
Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
Topics: Actuarial Analysis; Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Postoperative Period; Prednisolone; Retrospective Studies; Survival Analysis; Time Factors | 1993 |
Sandimmun Neoral: Taiwanese experience in renal transplant patients with special reference to patients with existing liver disease.
Topics: Administration, Oral; Cyclosporine; Dosage Forms; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Diseases; Metabolic Clearance Rate; Taiwan | 1996 |
Effect of combination therapy with cyclosporine and methotrexate on liver function test results in rheumatoid arthritis.
Topics: Alkaline Phosphatase; Antirheumatic Agents; Arthritis, Rheumatoid; Bilirubin; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Humans; Liver; Liver Diseases; Liver Function Tests; Methotrexate | 1997 |
Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine.
Topics: Adolescent; Adult; Aged; Chemistry, Pharmaceutical; Cyclosporine; Emulsions; Female; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Risk Factors | 1998 |
80 other study(ies) available for cyclosporine and Liver Dysfunction
| Article | Year |
|---|---|
The Effect of Cyclosporine and the Consequences in Hepatic and Renal Function Following Ischemic Stroke in a Rats' Model.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Brain Ischemia; Cyclosporine; Disease Models, Animal; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Rats, Wistar; Stroke; Time Factors | 2020 |
Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.
Topics: Age Factors; Cardiovascular Diseases; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus; Transplant Recipients | 2017 |
Complications in paediatric liver transplant from Kuwait when transplanted abroad.
Topics: Adolescent; Biliary Atresia; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Kuwait; Liver Diseases; Liver Transplantation; Male; Patient Transfer; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2012 |
Effect of intestinal atrophy and hepatic impairment induced by parenteral nutrition on drug absorption and disposition in rats.
Topics: Administration, Intravenous; Animals; Area Under Curve; Atrophy; Cyclosporine; Intestinal Mucosa; Intestines; Liver Diseases; Male; Parenteral Nutrition; Permeability; Phenolsulfonphthalein; Rats | 2015 |
Tacrolimus therapy causes hepatotoxicity in patients with a history of liver disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Monitoring; Electronic Health Records; Female; Humans; Immunosuppressive Agents; Liver Diseases; Male; Middle Aged; Republic of Korea; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors; Young Adult | 2015 |
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus | 2015 |
Two Cases With Developing Neurologic Complications After Liver Transplant.
Topics: Cyclosporine; Epilepsy; Female; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Middle Aged; Muscle Weakness; Paresis; Postoperative Complications; Reflex, Babinski; Tacrolimus | 2016 |
Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Topics: Adult; Cyclosporine; Disseminated Intravascular Coagulation; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Liver Diseases; Lung Diseases; Macrophage Activation Syndrome; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Serositis; Shock; Still's Disease, Adult-Onset; Young Adult | 2016 |
Cyclosporine A Suppressed Glucose Oxidase Induced P53 Mitochondrial Translocation and Hepatic Cell Apoptosis through Blocking Mitochondrial Permeability Transition.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Membrane Permeability; Cyclosporine; Cytochromes c; Gene Expression Regulation; Glucose Oxidase; Hep G2 Cells; Humans; Liver Diseases; Male; Mice; Mice, Inbred Strains; Mitochondrial Membranes; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sulfonamides; Tumor Suppressor Protein p53 | 2016 |
Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Antagonism; Ellagic Acid; Glutathione Transferase; Immunosuppressive Agents; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2008 |
Renal function in pediatric liver transplantation: a long-term follow-up study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Incidence; Infant; Inulin; Kaplan-Meier Estimate; Liver Diseases; Liver Transplantation; Male; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Severity of Illness Index; Survivors; Time Factors | 2008 |
Inhibition of the mitochondrial permeability transition by cyclosporin A prevents pyrazole plus lipopolysaccharide-induced liver injury in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cyclosporine; Lipid Peroxidation; Lipopolysaccharides; Liver; Liver Diseases; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitogen-Activated Protein Kinase 9; Necrosis; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Signal Transduction | 2009 |
Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclosporine; Female; Humans; Infant; Liver Diseases; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Models, Biological | 2009 |
Effect of immunosuppressant blood levels on serum concentration of interleukin-17 and -23 in stable liver transplant recipients.
Topics: Aged; Cohort Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interleukin-17; Interleukin-23; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Transplantation; Male; Middle Aged; Reference Values; Tacrolimus; Th1 Cells; Th2 Cells | 2009 |
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Topics: Acute Disease; Clinical Trials, Phase III as Topic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Diseases; Methotrexate; Organ Specificity; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Diseases; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2009 |
A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT.
Topics: Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Middle Aged; Multiple Myeloma; Skin Diseases; Transplantation, Autologous | 2010 |
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Chronic Disease; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus; Treatment Outcome | 2009 |
Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Interferons; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Ribavirin; Risk Factors; Treatment Outcome | 2009 |
Neurologic complications in adult living donor liver transplant patients: an underestimated factor?
Topics: Brain Diseases; Cohort Studies; Cyclosporine; Female; Hepatitis B; Hepatitis C; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Transplantation; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Seizures; Tacrolimus; Treatment Outcome | 2010 |
Long-term glomerular filtration rate in liver allograft recipients according to the type of calcineurin inhibitors.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Follow-Up Studies; Food, Formulated; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Function Tests; Liver Diseases; Liver Transplantation; Male; Middle Aged; Patient Selection; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Young Adult | 2009 |
Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.
Topics: Animals; Bone Marrow Transplantation; Chronic Disease; Colonic Diseases; Cyclosporine; Disease Models, Animal; Female; Graft vs Host Disease; Immunosuppressive Agents; Inflammation; Liver Diseases; Mice; Mice, Inbred C3H; Toll-Like Receptors; Transplantation, Isogeneic | 2010 |
Improved outcome after 'bottom-up' immunosuppression in liver transplant recipients with preoperative renal impairment.
Topics: Adult; Aged; Case-Control Studies; Creatinine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Pilot Projects; Renal Insufficiency; Retrospective Studies; Sirolimus; Treatment Outcome | 2010 |
Renal dysfunction in allogeneic hematopoietic cell transplantation.
Topics: Adult; Cyclosporine; Female; Glomerular Filtration Rate; Hematocrit; Hematopoietic Stem Cell Transplantation; Hemoglobins; Humans; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Male; Middle Aged; Pancytopenia; Platelet Count; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2002 |
Systemic lupus erythematosus with haemophagocytosis and severe liver disorder.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Liver Diseases; Lupus Erythematosus, Systemic; Prednisolone | 2002 |
Use of calcineurin inhibitors in pediatric liver transplantation: a single-center experience.
Topics: Adolescent; Azathioprine; Calcineurin Inhibitors; Child; Child, Preschool; Cyclosporine; Enzyme Inhibitors; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Diseases; Liver Transplantation; Prednisolone; Retrospective Studies | 2002 |
Thirteen years' experience in pediatric liver transplantation: differences between tacrolimus and cyclosporine.
Topics: Adolescent; Age Distribution; Biliary Atresia; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Infant; Infant, Newborn; Liver Diseases; Liver Transplantation; Lymphoproliferative Disorders; Male; Postoperative Complications; Reoperation; Retrospective Studies; Survival Analysis; Tacrolimus; Treatment Outcome | 2002 |
Basiliximab reduces acute liver allograft rejection in pediatric patients.
Topics: Adolescent; Antibodies, Monoclonal; Basiliximab; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Liver Diseases; Liver Transplantation; Male; Recombinant Fusion Proteins; Retrospective Studies; Tacrolimus; Time Factors | 2002 |
CD4 T lymphocytes cause hepatocyte apoptosis by releasing Th1 cytokines in cellular immunological liver injury.
Topics: Animals; Apoptosis; CD4-Positive T-Lymphocytes; Chemical and Drug Induced Liver Injury; Cyclosporine; Ear Diseases; Edema; Female; Hepatocytes; Immunity, Cellular; Immunosuppressive Agents; Interleukin-2; Liver Diseases; Mice; Mice, Inbred BALB C; Picryl Chloride; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2002 |
Renal failure and abdominal hypertension after liver transplantation: determination of critical intra-abdominal pressure.
Topics: Abdomen; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Function Tests; Liver Diseases; Liver Transplantation; Male; Middle Aged; Patient Selection; Postoperative Complications; Postoperative Period; Pressure; Renal Insufficiency; Respiration, Artificial; Treatment Outcome | 2002 |
Chronic cholestasis and cardiac mitochondrial function in Wistar rats: a model for cardiovascular alterations in chronic liver disease?
Topics: 1-Naphthylisothiocyanate; Animals; Calcium; Cardiovascular Diseases; Cholestasis; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Fibrosis; Liver Diseases; Mitochondria, Heart; Oxidative Stress; Rats; Rats, Wistar | 2003 |
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Resorption; Cholestasis; Collagen; Collagen Type I; Cyclosporine; Female; Femur Neck; Follow-Up Studies; Forearm; Fractures, Bone; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Norway; Osteocalcin; Osteoporosis; Peptide Fragments; Peptides; Postoperative Complications; Survival Analysis; Tacrolimus; Treatment Outcome; Waiting Lists | 2003 |
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation.
Topics: Area Under Curve; Circadian Rhythm; Cyclosporine; Humans; Immunosuppressive Agents; Liver Diseases; Liver Function Tests; Liver Transplantation; Middle Aged; Time Factors | 2003 |
Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment: single-center experience.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Portugal; Postoperative Complications; Retrospective Studies; Time Factors | 2003 |
Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents.
Topics: Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Liver Diseases; Male; Treatment Outcome | 2004 |
Short- and long-term results of liver transplantation in infants aged less than 6 months.
Topics: Body Weight; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infections; Liver Diseases; Liver Transplantation; Male; Methylprednisolone; Postoperative Complications; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2004 |
Possible causes of central pontine myelinolysis after liver transplantation.
Topics: Adult; Aged; Cyclosporine; Female; Humans; Hyponatremia; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Myelinolysis, Central Pontine; Osmolar Concentration; Postoperative Complications; Prevalence; Retrospective Studies; Risk Factors; Sodium | 2004 |
Role of the permeability transition pore in cytochrome C release from mitochondria during ischemia-reperfusion in rat liver.
Topics: Animals; Caspases; Cyclosporine; Cytochromes c; Drug Interactions; Hypoxia; Ischemia; Liver Diseases; Mitochondria; Mitochondria, Liver; Permeability; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reperfusion | 2004 |
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Child; Child, Preschool; Cholesterol; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Ischemia; Kidney; Lipid Metabolism; Liver Diseases; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome; Triglycerides | 2005 |
Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation.
Topics: Adolescent; Child; Child, Preschool; Chromium; Creatinine; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Infant; Liver Diseases; Liver Transplantation; Male; Metabolic Clearance Rate; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2005 |
Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver.
Topics: Animals; Antioxidants; Chaperonin 60; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Immunosuppressive Agents; Liver; Liver Diseases; Male; Malondialdehyde; Melatonin; Membrane Proteins; Metallothionein; Oxidative Stress; Rats; Rats, Wistar | 2005 |
Neuropsychiatric complications after liver transplantation: role of immunosuppression and hepatitis C.
Topics: Adult; Aged; Cyclosporine; Depressive Disorder; Female; Hepatitis C, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Liver Diseases; Liver Transplantation; Male; Medical Records; Middle Aged; Postoperative Complications; Retrospective Studies; Tacrolimus; Tennessee | 2006 |
The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Fluorescence Polarization Immunoassay; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Male; Middle Aged; Reproducibility of Results; Stem Cell Transplantation | 2006 |
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Busulfan; Chemical and Drug Induced Liver Injury; Cholangitis; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Diseases; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Incidence; Infant, Newborn; Liver Diseases; Liver Function Tests; Male; Melphalan; Middle Aged; Postoperative Complications; Risk Factors; Tacrolimus; Tissue Donors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2006 |
Pharmacokinetics of cyclosporine A after massive hepatectomy: a hint for small-for-size graft in living donor liver transplantation.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cyclosporine; Cytochrome P-450 CYP3A; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression; Hepatectomy; Immunosuppressive Agents; Liver; Liver Diseases; Liver Regeneration; Liver Transplantation; Living Donors; Male; Membrane Proteins; Organ Size; Polymerase Chain Reaction; Radioimmunoassay; Rats; Rats, Wistar; RNA, Messenger | 2007 |
The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats.
Topics: Acetylcysteine; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione Peroxidase; Liver; Liver Diseases; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Wistar; Superoxide Dismutase | 2008 |
Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Infections; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies | 2007 |
Clinical evolution in the first 3 months of patients after liver transplantation in maintenance phase converted from mycophenolate mofetil to mycophenolate sodium due to gastrointestinal complications.
Topics: Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Diseases; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies | 2007 |
Sirolimus conversion for renal preservation in liver transplantation: not so fast.
Topics: Antimetabolites; Calcineurin Inhibitors; Creatinine; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Renal Insufficiency, Chronic; Renal Replacement Therapy; Sirolimus; Tacrolimus; Treatment Outcome | 2008 |
Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
Topics: Adult; Aged; Antimetabolites; Calcineurin Inhibitors; Case-Control Studies; Creatinine; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Renal Insufficiency, Chronic; Renal Replacement Therapy; Retrospective Studies; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2008 |
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation.
Topics: Cyclosporine; Dihydropyridines; Eicosanoids; Endothelins; Female; Hemodynamics; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Radioimmunoassay; Renal Circulation; Retrospective Studies; Tacrolimus; Vasoconstriction | 1995 |
Endotoxemia is associated with renal dysfunction in liver transplantation recipients during the first postoperative week.
Topics: Adult; Aspartate Aminotransferases; Bilirubin; Case-Control Studies; Creatinine; Cyclosporine; Endotoxins; Female; Humans; Immunosuppressive Agents; Kidney; Liver Diseases; Liver Transplantation; Male; Postoperative Complications; Prednisone; Time Factors | 1995 |
Control of glucan-induced systemic granulomatosis by cyclosporine A.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chemotaxis; Cyclosporine; Female; Glucans; Granuloma, Foreign-Body; Liver Diseases; Lung Diseases; Macrophages; Rats; Rats, Inbred Lew; Splenic Diseases | 1995 |
Cyclosporine-induced worsening of hepatic dysfunction in a patient with Crohn's disease and enterocutaneous fistula.
Topics: Adult; Bilirubin; Chemical and Drug Induced Liver Injury; Crohn Disease; Cutaneous Fistula; Cyclosporine; Humans; Intestinal Fistula; Liver Diseases; Male | 1995 |
Optimal immunosuppressive clinical regimen in liver transplantation.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antilymphocyte Serum; Cause of Death; Cyclosporine; Drug Administration Schedule; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Liver Diseases; Liver Transplantation; Methylprednisolone; Middle Aged; Muromonab-CD3; Retrospective Studies; Risk Factors; Survival Rate; Time Factors | 1994 |
Possible transmission of sarcoidosis via allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Humans; Liver Diseases; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Sarcoidosis; Transplantation, Homologous | 1994 |
[Can the quality of a modest liver transplantation program compare to international standards? Results in Inselspital Berne].
Topics: Adult; Aged; Azathioprine; Cyclosporine; Female; Graft Rejection; Hospitals, Community; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Outcome Assessment, Health Care; Postoperative Complications; Retrospective Studies; Switzerland | 1994 |
[Orthotopic liver transplantation (first clinical experience)].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Carcinoma, Hepatocellular; Child; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Liver Diseases; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reoperation; Time Factors | 1993 |
Serum bile acids and esterified bilirubin in early detection and differential diagnosis of hepatic dysfunction following orthotopic liver transplantation.
Topics: Bile Acids and Salts; Bilirubin; Cyclosporine; Diagnosis, Differential; Esters; Follow-Up Studies; Graft Rejection; Humans; Liver Diseases; Liver Transplantation; Postoperative Complications; Prospective Studies | 1993 |
CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Anticonvulsants; beta-Thalassemia; Blood Transfusion; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Clonazepam; Coma; Combined Modality Therapy; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hemosiderosis; Humans; Hypertension; Immunosuppressive Agents; Incidence; Infant; Liver Diseases; Magnesium Deficiency; Magnetic Resonance Imaging; Male; Nervous System Diseases; Retrospective Studies; Risk Factors; Seizures; Tomography, X-Ray Computed; Transplantation Conditioning; Treatment Failure; Vision Disorders | 1996 |
Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid.
Topics: Adrenal Cortex Hormones; Bile Duct Diseases; Bilirubin; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Fibrosis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Male; Severe Combined Immunodeficiency; Skin Diseases; Ursodeoxycholic Acid | 1997 |
Successful treatment with cyclosporine in a case of hemophagocytic syndrome manifesting as severe liver dysfunction.
Topics: Adult; Alanine Transaminase; Bilirubin; Bone Marrow Cells; Cyclosporine; Female; Ferritins; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-6; Liver; Liver Diseases; Platelet Count; Receptors, Interleukin-2 | 1997 |
Combined liver-kidney transplantation: long-term follow-up in 18 patients.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prednisolone; Reoperation; Survival Rate; Tacrolimus; Time Factors | 1998 |
Liver transplantation in children for metabolic diseases.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infant; Liver Diseases; Liver Transplantation; Living Donors; Male; Metabolic Diseases; Racial Groups; Retrospective Studies; Survival Rate; Tissue Donors | 1998 |
[Liver transplantation: experiences and results of a program at the University of Liege].
Topics: Actuarial Analysis; Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Belgium; Chronic Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Diseases; Liver Transplantation; Myocardial Infarction; Postoperative Complications; Reoperation; Survival Rate; Tacrolimus; Time Factors; Waiting Lists | 1998 |
Does cyclosporin A worsen liver function in patients with inflammatory bowel disease and total parenteral nutrition?
Topics: Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Diseases; Liver Function Tests; Male; Parenteral Nutrition, Total; Retrospective Studies | 2000 |
Paediatric liver transplantation: Queen Mary Hospital experience.
Topics: Biliary Atresia; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Liver Diseases; Liver Transplantation; Male; Portoenterostomy, Hepatic | 1998 |
Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.
Topics: Adolescent; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Heart Ventricles; Humans; Immunosuppressive Agents; Infant; Liver Diseases; Liver Transplantation; Male; Tacrolimus; Ultrasonography; Ventricular Function, Left | 2001 |
Cyclosporin A causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine.
Topics: Animals; Body Weight; Calcium; Chemical and Drug Induced Liver Injury; Cyclosporine; Dietary Supplements; Dinoprostone; Eating; Glycine; Hypoxia; Immunosuppressive Agents; Kupffer Cells; Liver Diseases; Male; Mitochondria, Liver; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Urea | 2001 |
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.
Topics: Adult; Calcineurin Inhibitors; Creatinine; Cyclosporine; Female; Hepatorenal Syndrome; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Analysis; Tacrolimus; Time Factors | 2001 |
Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Liver; Liver Diseases; Male; Mice; Mice, Inbred Strains; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2001 |
Nocardiosis in tropical renal transplant recipients.
Topics: Adult; Chronic Disease; Cohort Studies; Cyclosporine; Female; Humans; India; Kidney Transplantation; Liver Diseases; Male; Nocardia Infections; Retrospective Studies; Risk Factors; Time Factors; Tropical Climate; Tuberculosis | 2002 |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft Rejection; Hepatic Artery; Hepatitis; Humans; Immunity, Cellular; Infant; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Tacrolimus | 1992 |
Liver disease in renal transplant recipients.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Granuloma; Hepatitis; Hepatitis B; Hepatitis E; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver; Liver Cirrhosis; Liver Diseases; Prednisolone; Tuberculosis | 1992 |
Five-year results of thoracic duct drainage in living related donor kidney transplantation.
Topics: Azathioprine; Creatinine; Cyclosporine; Graft Survival; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver Diseases; Lymphocyte Depletion; Survival Analysis; Thoracic Duct | 1992 |
Renal transplant recipients and chronic liver disease: statistical evaluation of predisposing factors.
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Female; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Liver Diseases; Male; Methylprednisolone; Middle Aged; Risk Factors | 1992 |
The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease.
Topics: Aryl Hydrocarbon Hydroxylases; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Female; Humans; Liver Diseases; Male; Microsomes, Liver; Oxidoreductases, N-Demethylating | 1992 |
Cyclosporin for inflammatory pseudotumour.
Topics: Adult; Cyclosporine; Granuloma, Plasma Cell; Humans; Leukocyte Count; Liver Diseases; Male; Tomography, X-Ray Computed | 1992 |
Acute adenovirus hepatitis in liver transplant recipients.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Azathioprine; Biliary Atresia; Child, Preschool; Cyclosporine; Hepatitis, Viral, Human; Humans; Infant; Liver Diseases; Liver Transplantation; Necrosis; Prednisone; Time Factors | 1992 |
Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Enalapril; Kidney Diseases; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Spironolactone | 1991 |
Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. A retrospective study in 80 patients with follow-up of 60 months.
Topics: Adolescent; Adult; Cholangitis; Chronic Disease; Cyclosporine; Female; Heart Transplantation; Hepatitis B; Hepatitis C; Hepatitis E; Humans; Liver; Liver Diseases; Male; Middle Aged; Retrospective Studies | 1991 |